MustGrow Biologics Corp.: MustGrow Achieves Control of Root-Rot Disease Aphanomyces in Greenhouse Trials
Plants treated with MustGrow s biopesticide were robust in plant and root system health.
Aphanomyces
90% of Saskachewan pulse crop fields have shown
Aphanomyces
MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (
MustGrow ) is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on
Aphanomyces euteiches zoospores (
Aphanomyces ) via an independent third party. Control in greenhouse soil was recorded across a range of economic application rates. MustGrow will advance to larger scale field tests in 2021 to be conducted under the recently-announced collaborative Canadian field trials program with NexusBioAg, a division of Univar Solutions Inc. Study results and applicability are patent-protected under MustGrow s existing suite of issued patents.